Join Now

Author Archives: admin

AdvaMed Request for Tariff Exclusions for Medical Technology Products

The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]

Posted in COVID-19 Updates, Utah's Life Sciences Companies | Leave a comment

PhotoPharmics Gets FDA Breakthrough Status for Parkinson’s PhotoTherapy

PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. “Hats off to Utah’s PhotoPharmics,” said Kelvyn Cullimore, president and CEO of BioUtah. “Earning this Breakthrough designation is a significant value driver for a privately-owned device company.” “Our device is […]

Posted in Life Sciences Industry News | Leave a comment

Sodium Chloride(NaCI)Aerosol Test Final Report

Summary: This procedure was performed to evaluate the particle penetration and air flow resistance properties of filtration materials. A neutralized, poly-dispersed aerosol of sodium chloride(NaCI) was generated and passed through the test article. The performance of the test article was assessed by measuring the concentration of salt particles penetrating the test article compared to the […]

Posted in Policy News | Leave a comment

KidneyIntelX™ to predict major adverse kidney events in COVID-19 patients

Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX™ platform will be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the risk of adverse kidney events in patients diagnosed with COVID-19. Acute and chronic kidney disease is strongly associated with severity […]

Posted in COVID-19 Updates | Leave a comment

FDA Grants Breakthrough Designation for Non-Invasive Phototherapy Device in Parkinson’s Disease

PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. This prescription device is intended as an adjunct therapy for the treatment of Parkinson’s disease. It is […]

Posted in Life Sciences Industry News | Leave a comment

Lunch and Learn: What to Know About 409A Valuations

Gregg Hamilton-Piercy, The MFA Companies & Kurt Sheline, Echo Health Ventures, will discuss some of the most common valuation methods. Join Gregg Hamilton-Piercy, CFA, ASA, The MFA Companies, and Kurt Sheline, Echo Health Ventures, for a Lunch and Learn discussion on some of the most common valuation methods being used, the typical investment terms to expect from […]

Posted in Life Sciences Events | Leave a comment

Lunch & Learn: The Payer Perspective

Join Cambia Grove for The Payer Perspective with Nic Anderson, Managing Partner at LDD Partners, and Jeremy Porter, Operating Partner at Waveny Ventures, to discuss incorporating health economics and a market access strategy into your business plan. This Lunch & Learn will be taking place virtually.  Learn more and register here.

Posted in Life Sciences Events | Leave a comment

Merit Medical Systems Designs and Produces Sample Collection and Transport Kit

Press release courtesy of globenewswire.com April 20, 2020 09:25 ET | Source: Merit Medical Systems, Inc. SOUTH JORDAN, Utah, April 20, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it has commenced production of a sample collection […]

Posted in COVID-19 Updates | Leave a comment

NIH announces strategy for developing COVID-19 drugs, vaccines

Drug companies will collaborate across hundreds of clinical trials in effort to coordinate private coronavirus research, which has been marked by chaos thus far The National Institutes of Health announced an initiative Friday to unify disparate efforts across the drug industry to respond to the coronavirus-related pandemic. Pharmaceutical companies will collaborate across hundreds of COVID-19 […]

Posted in COVID-19 Updates | Leave a comment

FDA Clears New Disposable Fog-Free Articulating 5mm Laparoscope

SALT LAKE CITY, April 14, 2020 /PRNewswire/ — Xenocor, Inc. announced the FDA cleared the new Xenocor Disposable 5mm Articulating Laparoscope for minimally invasive abdominal and thoracic surgery. The Xenoscope 5mm articulating disposable laparoscope is designed to improve image quality, reduce fog, lower hospital costs, and reduce bio-hazard risk for the patient and staff. Read the article below on […]

Posted in Life Sciences Industry News | Leave a comment

REGISTER NOW: Virtual Trade Mission to the U.A.E. on April 27-28, 2020

Connect directly with business and government leaders from the United Arab Emirates in a virtual trade mission hosted by World Trade Center Utah and the U.S.-U.A.E. Business Council. This two-day digital event provides Utah companies with an opportunity to forge strong business ties in the Middle East without leaving home. When you register, you will […]

Posted in Policy News | Leave a comment

Predictive Submits Emergency Use Authorization Application for Treatment of Acute Respiratory Distress Syndrome Secondary to COVID -19 with Umbilical Cord Mesenchymal Stem Cells

Article courtesy of Predictive Techgroup Newsroom SALT LAKE CITY, April 13, 2020 (GLOBE NEWSWIRE) – Predictive Biotech, a wholly owned subsidiary of Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), announced that on April 9th it submitted an Emergency Use Authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for the immediate use of mesenchymal […]

Posted in COVID-19 Updates | Leave a comment